Replies to post #16988 on OTC/PINK Breaking Material Events

[HDOGTX]

EQUR 8k, FDA Approval

http://archive.fast-edgar.com/20170221/AOKZD22CZ22TD2Z2222Q22ZKOAKNZZ224U92

On February17, 2017, the Registrant received FDA's IDE approval letter which authorized the Registrant to begin a new 10-patient feasibility study to be conducted at up to 5 sites rather than the October 14, 2016 FDA approval for only one site. The FDA approval for expanding the study should expedite the Registrant's ability to enlist patients for the study. The Registrant plans to submit a safety report with the FDA following which we intend to proceed with a trial, which contemplates testing the BST Device with 90 patients